- Home
- MLSS vs CTSO Comparison
MLSS vs CTSO Comparison
Compare MLSS & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLSS
- CTSO
- Stock Information
- Founded
- MLSS 1989
- CTSO 1997
- Country
- MLSS United States
- CTSO United States
- Employees
- MLSS N/A
- CTSO N/A
- Industry
- MLSS Industrial Specialties
- CTSO Medical/Dental Instruments
- Sector
- MLSS Health Care
- CTSO Health Care
- Exchange
- MLSS Nasdaq
- CTSO Nasdaq
- Market Cap
- MLSS 50.0M
- CTSO 52.6M
- IPO Year
- MLSS 1995
- CTSO N/A
- Fundamental
- Price
- MLSS $0.67
- CTSO $1.07
- Analyst Decision
- MLSS Buy
- CTSO Buy
- Analyst Count
- MLSS 1
- CTSO 2
- Target Price
- MLSS $1.25
- CTSO $5.50
- AVG Volume (30 Days)
- MLSS 88.0K
- CTSO 136.2K
- Earning Date
- MLSS 08-13-2025
- CTSO 08-12-2025
- Dividend Yield
- MLSS N/A
- CTSO N/A
- EPS Growth
- MLSS N/A
- CTSO N/A
- EPS
- MLSS N/A
- CTSO N/A
- Revenue
- MLSS $8,613,503.00
- CTSO $35,332,238.00
- Revenue This Year
- MLSS $29.14
- CTSO $18.34
- Revenue Next Year
- MLSS $20.19
- CTSO $19.82
- P/E Ratio
- MLSS N/A
- CTSO N/A
- Revenue Growth
- MLSS N/A
- CTSO 15.37
- 52 Week Low
- MLSS $0.57
- CTSO $0.71
- 52 Week High
- MLSS $1.39
- CTSO $1.61
- Technical
- Relative Strength Index (RSI)
- MLSS 35.08
- CTSO 52.96
- Support Level
- MLSS $0.61
- CTSO $0.93
- Resistance Level
- MLSS $0.73
- CTSO $1.16
- Average True Range (ATR)
- MLSS 0.07
- CTSO 0.11
- MACD
- MLSS -0.00
- CTSO -0.02
- Stochastic Oscillator
- MLSS 38.71
- CTSO 45.77
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.